‘Insights on Innovation Series’ - Dr. Jim Walsh

‘Insights on Innovation Series’

Seminar Two

Insights from Dr. Jim Walsh

Adjunct Professor and Bio-Innovator in Residence at DCU

29th May 2015
12.30 – 2pm
Invent, DCU

Light lunch available at 12.30pm

Dr. Jim Walsh, Adjunct Professor and Bio-Innovator in Residence at Dublin City University will speak about his experiences in innovative start-ups in Ireland.

Dr. Jim Walsh has 25 years general management experience in the Healthcare industry with particular experience in Diagnostics. He is currently Executive Director and CSO of Trinity Biotech Plc, (NASDAQ: TRIB) an Irish Diagnostics company and is Executive Chairman of Biosensia Ltd. An Irish Point of Care Diagnostics Company. Previously Dr. Walsh was Executive Chairman of GenCell Biosystems Ltd, a Genomics platform company, acquired by Becton Dickenson in October 2014. Until 2010 Dr. Walsh was CEO of Stokes Bio Ltd. a company specialising in the area of Molecular Diagnostics, acquired by Life Technologies. Dr. Walsh is also an investor in and a Director of a number of early stage Diagnostic companies, including Enzolve Technologies Ltd. (Paediatric testing), Epona Biotech (Animal Haematology), Crescent Diagnostics Ltd., (Bone Health).

Previously Dr. Walsh was Managing Director of Cambridge Diagnostics Ltd. a wholly owned subsidiary of Alere. Before joining CDL he worked with Fleming GmbH as R&D Manager.

Born in Ireland in 1958, Dr Walsh is a graduate of the National University of Ireland and holds a Doctorate in Inorganic Chemistry and Post Doctorate qualifications in Immunochemistry.